Clinical Trial Update: Thiamine as a Metabolic Resuscitator in Septic Shock [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials evaluating thiamine as a metabolic resuscitator in septic shock were completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Thiamine (thiamine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Septic Shock | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-15